Complete Wegovy vs Mounjaro Treatment Comparison
Why Change From Wegovy To Mounjaro: Complete Dose Availability Analysis
When considering whether to change from Wegovy to Mounjaro, having access to every dose throughout your treatment journey becomes crucial for maintaining therapeutic continuity. EverydayMeds stocks all five Wegovy doses (0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg) alongside the complete Mounjaro range, eliminating the common problem of switching pharmacies mid-treatment due to stock shortages. This comprehensive availability means patients can make informed treatment decisions based purely on clinical suitability rather than supply constraints.
The decision to change from Wegovy to Mounjaro often centres on the different mechanisms of action and individual response patterns. Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors as a dual agonist. Both medicines require careful dose escalation over 16-17 weeks to reach maintenance levels, making consistent supply availability essential for treatment success. Our complete stock ensures seamless progression whether you're starting fresh or switching between treatments.
Wegovy vs Mounjaro Pricing: Complete Treatment Cost Analysis
Understanding the full cost implications when you change from Wegovy to Mounjaro requires examining pricing across all dose levels. Wegovy single pens range from £79.99 for 0.25mg starter doses to £209.99 for 2.4mg maintenance pens. Our bundle options provide convenient multi-month supplies, such as the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99 or the Ultimate Stability Trio (three 2.4mg pens) for £649.99. New customers benefit from discount code FIRST40 applied at checkout, whilst returning patients use code DOSE25.
Cost comparison between Wegovy and Mounjaro involves more than single pen prices, encompassing long-term maintenance costs and dosing frequency. Both treatments require once-weekly administration, but their escalation schedules and maintenance doses differ. EverydayMeds' transparent pricing structure eliminates surprise costs, with all prices including prescriber assessment, clinical review, and next-day cold-chain delivery. This comprehensive pricing approach helps patients budget effectively whether continuing current treatment or making the change from Wegovy to Mounjaro.
Clinical Evidence: Wegovy STEP Trials vs Mounjaro SURMOUNT Data
Clinical evidence supporting both treatments comes from robust trial programmes, though direct head-to-head comparisons remain limited due to different study designs and patient populations. Wegovy's efficacy data stems from the STEP trial programme, where patients taking semaglutide alongside diet and exercise achieved average weight reductions of approximately 15% at 68 weeks in STEP 1 (Wilding et al., NEJM, 2021). STEP 5 demonstrated sustained weight management with approximately 15.2% average reduction maintained at 2 years.
Mounjaro's clinical profile derives from the SURMOUNT trials, showing its dual GIP+GLP-1 mechanism in weight management settings. When considering whether to change from Wegovy to Mounjaro, patients should discuss their individual response patterns and treatment goals with their prescriber rather than comparing trial percentages directly. Both medicines are prescription-only treatments requiring ongoing medical supervision and lifestyle modifications including reduced-calorie diet and increased physical activity.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a natural hormone that regulates appetite and food intake. This mechanism works primarily in the brain's appetite control centres, reducing hunger signals and promoting feelings of fullness after smaller meals. The medication may also slow gastric emptying, helping patients feel satisfied for longer periods after eating. Additionally, Wegovy can reduce food cravings, particularly for high-calorie foods, supporting adherence to reduced-calorie dietary plans. Understanding this single-target approach helps patients considering whether to change from Wegovy to Mounjaro appreciate the mechanistic differences between treatments.
Ordering Process: From Assessment To Delivery
Accessing Wegovy through EverydayMeds involves a streamlined three-step process designed for convenience and clinical safety. The journey begins with a comprehensive 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Following submission, our registered prescribers conduct thorough reviews within three working days (or 24 hours with express service) to ensure treatment suitability and safety. Once approved, orders are dispatched via next-day delivery using specialist cold-chain transportation to maintain medication integrity. This efficient process applies whether you're starting Wegovy fresh or looking to change from Wegovy to Mounjaro, with our clinical team providing guidance throughout. All consultations meet GPhC standards (#9012878) with ongoing prescriber support available for treatment optimisation.
Storage and Practical Considerations: Wegovy vs Mounjaro Comparison
Storage requirements represent a key practical difference when deciding to change from Wegovy to Mounjaro, particularly for patients who travel frequently or have variable schedules. Wegovy maintains stability for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigerated storage (2-8°C) before first use and utilise pre-filled injection pens for once-weekly administration. Wegovy employs Novo Nordisk's FlexTouch pen system, whilst Mounjaro uses a similar auto-injector design. The dose escalation schedules differ slightly, with Wegovy following a 0.25mg→0.5mg→1mg→1.7mg→2.4mg progression over 16 weeks, whilst Mounjaro uses 2.5mg→5mg→7.5mg→10mg→15mg escalation over 20 weeks before reaching maintenance dosing.
Treatment Switching Considerations: Wegovy To Mounjaro Transition
Patients considering the change from Wegovy to Mounjaro must navigate specific transition protocols under prescriber guidance. Unlike switching between generic equivalents, moving from semaglutide to tirzepatide involves changing to an entirely different mechanism of action, requiring careful timing and potential washout periods. The decision often reflects individual response patterns, side effect profiles, or insurance coverage changes rather than treatment failure. Clinical assessment becomes particularly important during transitions to ensure appropriate starting doses and monitoring schedules.
EverydayMeds' comprehensive stock holdings support smooth transitions by maintaining immediate availability of both first-line treatments and alternative options. Our clinical team coordinates with patients' existing prescribers or provides independent assessment services to facilitate safe treatment changes. This integrated approach ensures patients receive continuous support whether maintaining current therapy or implementing the change from Wegovy to Mounjaro based on evolving clinical needs.
Complete Your Treatment Journey: Order Wegovy Today
Transform your weight management approach with Wegovy's proven GLP-1 mechanism, available in all doses from our GPhC-registered pharmacy (#9012878). New customers benefit from discount code FIRST40 applied at checkout, reducing costs whilst accessing comprehensive prescriber support and next-day delivery services. Whether you're beginning treatment or considering the change from Wegovy to Mounjaro, our clinical team provides expert guidance tailored to your individual circumstances. Complete your online assessment today via https://everydaymeds.co.uk/collections/wegovy to begin your consultation. Our prescription-only medicine service ensures safe, regulated access with ongoing clinical monitoring for optimal treatment outcomes.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
